Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-06

Clinical Trial Update: The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors [NA]

View source ↗

Summary

Completed clinical trial update evaluating the effects of soy protein and soy isoflavones on glycemic control, insulin sensitivity, and cardiovascular risk fact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soy Isoflavones (isoflavones from soy)
  • Soy protein (soy protein)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Diabetes, Cardiovascular Risk | NA | Status: COMPLETED